Issue 56 • November 2022

What is taboo tech?

China’s domestic agenda

Renal denervation for hypertension

Diabetes devices: Easing the burden of care for women

November marks Diabetes Awareness Month.

In association with

Issue 56

Brought to you by

11/23/2022 21:52:00
  • Home | Diabetes is a global health problem
  • In this issue
  • Contents
  • Formacoat Company Insight
  • Formacoat
  • BioInteractions Company Insight
  • BioInteractions
  • Briefing
  • Industry news
  • The medical industry briefing
  • Alleima Company Insight
  • Alleima
  • Picosun Company Insight
  • Sartorius
  • Comment
  • Development of automated insulin delivery systems simplifies diabetes management
  • Wearable technology market continues to rise
  • Covid-19 pandemic milked dry? Major players shifting away from Covid-19 testing
  • mdi Consultants
  • Accumold
  • ElectroCraft Company Insight
  • ElectroCraft
  • In Depth
  • What is taboo tech and what opportunities does it hold for investors?
  • What China’s domestic agenda means for foreign medical device developers
  • Diabetes devices: Easing the burden of care for women
  • Renal denervation for hypertension: a safe and effective therapy? SEO box: ren
  • On Line Controls
  • Melexis
  • Events
  • Next Issue